In sickle cell anemia, the most noteworthy change is the substitution of the amino acid glutamate with valine at position 6 of the \(\beta\)-globin chain in hemoglobin.
This substitution takes place due to a point mutation in the DNA sequence of the hemoglobin gene. The normal codon for glutamate is GAG, and the mutation changes this to GUG, the codon for valine.
- Glutamate (Glu) is a hydrophilic, negatively charged amino acid. This means it interacts well with water and helps in maintaining the solubility of hemoglobin.
- Valine (Val), on the other hand, is nonpolar and hydrophobic. It doesn't interact as well with water and causes hemoglobin molecules to stick together.
This change in the amino acid's nature leads to the aggregation of hemoglobin, causing red blood cells to take on a sickle-like shape. These sickled cells can't carry oxygen efficiently and can block blood vessels, leading to various health complications commonly associated with sickle cell anemia.